z-logo
open-access-imgOpen Access
LIVER TRANSPLANTATION IN PATIENTS WITH HEPATORENAL SYNDROME: BENEFICIAL USE OF ANTI-IL2.
Author(s) -
Paola Casciato,
Sabela Fernández,
Omar Galdame,
Juan Carlos Bandi,
Alejandra Villamil,
M Ciardullo,
Eduardo de Santibáñes,
Adrián Gadano
Publication year - 2004
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200407271-01010
Subject(s) - daclizumab , medicine , basiliximab , calcineurin , hepatorenal syndrome , tacrolimus , transplantation , gastroenterology , liver transplantation , nephrotoxicity , renal function , creatinine , liver function , urology , cirrhosis , kidney

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here